-
Cost-Effectiveness Analysis of Isavuconazole vs. Liposomal Amphotericin B for the Treatment of Invasive Mucormycosis in Morocco
Sep 9, 2025, 16:22 PM -
A Systematic Literature Review of Cost of Illness Studies on Atrial Fibrillation With Focus on the Methodologies Economic Burden and Factors Influencing the Cost of Atrial Fibrillation Among European and North American Countries
Sep 9, 2025, 16:22 PM -
Listening to the Voice of the Patient: Insights From a Survey on the Burden of Recurrent Respiratory Papillomatosis in the United States
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Follow-up Strategies for Localized or Locally Advanced Renal Cell Carcinoma From the UK NHS Perspective
Sep 9, 2025, 16:22 PM -
France and the Challenge of High-Cost Innovative Drug Expenditures in Hospitals
Sep 9, 2025, 16:22 PM -
Evolution of Health Technology Assessment (HTA) in India: A Scoping Review and Thematic Analysis
Sep 9, 2025, 16:22 PM -
Psychometric Evaluation of the Immune Thrombocytopenic Purpura Patient Assessment Questionnaire Item-10 (Physical Fatigue) and Idiopathic Thrombocytopenic Purpura Bleeding Scale Using LUNA 3 Phase 3 Trial Data
Sep 9, 2025, 16:22 PM -
Modeling Framework for Assessing Cost-Effectiveness of New Treatments in Chronic Kidney Disease
Sep 9, 2025, 16:22 PM -
Estimating the Broader Societal Impact of Ocrelizumab for Multiple Sclerosis (MS) in Latin America (LATAM) Using a Social Impact Approach
Sep 9, 2025, 16:22 PM -
The Efficacy of Multilevel Pairwise Meta-Regression in the Mitigation of Aggregation Bias: A Simulation Study
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization (HCRU) and Associated Costs in Patients With Advanced Merkel Cell Carcinoma (aMCC) in Germany: Analysis From the MCC TRIM Registry Study
Sep 9, 2025, 16:22 PM -
Development of the Eating Drivers Diary (EDDY): A Novel Patient-Reported Outcome Measure for Use in Clinical Trials of Medications for Weight Reduction
Sep 9, 2025, 16:22 PM -
Real-World Assessment Process to Identify Fit-for-Purpose Data Sources to Meet Milestones for Post-Marketing Requirements (PMR), Post Authorization Safety Studies (PASS), and Health Technology Assessment (HTA) Submissions Utilizing Source Exploration...
Sep 9, 2025, 16:22 PM -
Nutritional Profile and Cost Evaluation of Elderly Patients in Home Care Within the Brazilian Private Health Sector: A Retrospective Study
Sep 9, 2025, 16:22 PM -
Supplementing Single-Arm Trial Data in NICE Submissions: Are Synthetic Approaches Leading the Charge?
Sep 9, 2025, 16:22 PM -
Use of High-Cost Medicines in Secondary Care Settings in the English National Health Service
Sep 9, 2025, 16:22 PM -
Comparing Countries’ Time to Treatment Initiation: A Study of Metastatic Breast Cancer in Austria and the United States
Sep 9, 2025, 16:22 PM -
Evaluating the Cost-Effectiveness of Nasal Adrenaline Spray vs. Adrenaline Autoinjector for Treatment of Anaphylaxis: A Cost-Utility Modeling Approach
Sep 9, 2025, 16:22 PM -
Confirmation of Diagnosis Method for Robust Participant Selection in Direct-to-Patient Real-World Evidence Studies
Sep 9, 2025, 16:22 PM -
Pharmacists’ Engagement With Pharmaceutical Care in Pakistan: Insights From a Cross-Sectional Survey on Knowledge, Attitudes, Practices, and Barriers
Sep 9, 2025, 16:22 PM